Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from the ovary and is characterized by the presence of small malignant cells. It includes small cell carcinoma, hypercalcemic type and small cell carcinoma, pulmonary type.
Biomarker and diagnostic research for ovarian small cell carcinoma has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
195 publications have been identified in PubMed for ovarian small cell carcinoma. Research spans Basic Science / Preclinical (41%), Review / Meta-Analysis (14%), and Gene Therapy / Novel Therapeutics (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 80 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 28 | 14% |
New treatment approaches | 21 | 11% |
Clinical study results | 19 | 10% |
Patient case studies | 17 | 9% |
Testing and diagnosis research | 16 | 8% |
Disease patterns and progression | 14 | 7% |
Arora T (2026). [PMID: 33620837](https://pubmed.ncbi.nlm.nih.gov/33620837/). *Unknown Journal*. [Basic Science / Preclinical]
Jiang J (2026). [PMID: 41807550](https://pubmed.ncbi.nlm.nih.gov/41807550/). *NPJ Precis Oncol*. [Basic Science / Preclinical]
Tan GYT (2026). [PMID: 41933240](https://pubmed.ncbi.nlm.nih.gov/41933240/). *EMBO Mol Med*. [Gene Therapy / Novel Therapeutics]
Maccio L (2026). [PMID: 41449215](https://pubmed.ncbi.nlm.nih.gov/41449215/). *Virchows Arch*. [Review / Meta-Analysis]
Daoud S (2026). [PMID: 41988129](https://pubmed.ncbi.nlm.nih.gov/41988129/). *Front Oncol*. [Case Report / Case Series]
Qiu T (2026). [PMID: 41480895](https://pubmed.ncbi.nlm.nih.gov/41480895/). *J Am Chem Soc*. [Basic Science / Preclinical]
Chen S (2026). [PMID: 42277572](https://pubmed.ncbi.nlm.nih.gov/42277572/). *J Cell Mol Med*. [Review / Meta-Analysis]
Li J (2026). [PMID: 41845303](https://pubmed.ncbi.nlm.nih.gov/41845303/). *BMC medical imaging*. [Case Report / Case Series]
Sachdeva M (2026). [PMID: 41883867](https://pubmed.ncbi.nlm.nih.gov/41883867/). *Ther Adv Med Oncol*. [Review / Meta-Analysis]
Awosika AO (2026). [PMID: 30725807](https://pubmed.ncbi.nlm.nih.gov/30725807/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]